Novartis Institutes for Biomedical Research Business Analyst Salaries in Boston
The average Novartis Institutes for Biomedical Research Business Analyst in Boston earns an estimated $74,227 annually, which includes an estimated base salary of $69,310 with a $4,917 bonus. Novartis Institutes for Biomedical Research's Business Analyst compensation is $9,244 less than the US average for a Business Analyst. Business Analyst salaries at Novartis Institutes for Biomedical Research in Boston can range from $55,000 - $104,500.
In Boston, The Marketing Department at Novartis Institutes for Biomedical Research earns $26,580 more on average than the Admin Department.
Last updated 3 years ago.
- $69,310
- avg. base
- $4,917
- avg. bonus
Business Analyst Salaries at Novartis Institutes for Biomedical Research
In Boston, Business Analysts earn $1,984 more than Business Analysts, and $3,702 less than Copywriters.
Compensation at Novartis Institutes for Biomedical Research by Department
In Boston, The Marketing Department averages $26,580 more than the Admin Department, and $258 less than the Business Development Department
Business Analyst Compensation by Gender (All Companies)
The average female Business Analyst at companies similar size to Novartis Institutes for Biomedical Research reported making $85,427, while the average male Business Analyst at similar sized companies reported making $93,384.
Business Analyst Compensation by Ethnicity (All Companies)
The average Native American Business Analyst at companies similar size to Novartis Institutes for Biomedical Research reported making $97,000, while the average African American/Black Business Analyst at similar sized companies reported making $76,443.
How Business Analysts at Novartis Institutes for Biomedical Research Rate Their Compensation
The majority of Business Analysts at Novartis Institutes for Biomedical Research believe they're compensated fairly. 100% of Business Analysts at Novartis Institutes for Biomedical Research say they receive annual bonuses, and the majority (43%) are not satisfied with their benefits. See more compensation ratings at Novartis Institutes for Biomedical Research
